An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
Author:
Funder
UCB Pharma
Publisher
Elsevier BV
Subject
Behavioral Neuroscience,Neurology (clinical),Neurology
Reference17 articles.
1. Comparative retention rates and long-term tolerability of new antiepileptic drugs;Chung;Seizure,2007
2. Safety profile of levetiracetam;Harden;Epilepsia,2001
3. Keppra® (levetiracetam tablets and oral solution): US prescribing information,2015
4. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug;French;Epilepsy Res,2001
5. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy;Werhahn;Epilepsia,2015
Cited by 131 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of Effectiveness of Brivaracetam and Levetiracetam for Prophylaxis of Early Post-Traumatic Seizures: A Prospective Comparative Interventional Study;Asian Journal of Neurosurgery;2024-09-10
2. A single exposure to brivaracetam or perampanel does not cause cell death in neonatal rats;Frontiers in Pediatrics;2024-09-09
3. An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database;Epilepsy Research;2024-07
4. Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures;Epilepsy & Behavior;2024-07
5. Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy;Advances in Therapy;2024-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3